Food and Drug Administration regulators cleared a Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 on Friday.
The shot could be available for young children next week after the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention reconvenes to provide feedback, after which CDC Director Rochelle Walensky will presumably give the final green light, according to the Washington Post.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.